Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors

被引:58
|
作者
Parambi, Della Grace Thomas [1 ]
Oh, Jong Min [2 ,3 ]
Baek, Seung Cheol [2 ,3 ]
Lee, Jae Pil [2 ,3 ]
Tondo, Anna Rita [4 ]
Nicolotti, Orazio [5 ]
Kim, Hoon [2 ,3 ]
Mathew, Bijo [6 ,7 ]
机构
[1] Jouf Univ, Dept Pharmaceut Chem, Sakaka 2014, Al Jouf, Saudi Arabia
[2] Sunchon Natl Univ, Dept Pharm, Sunchon 57922, South Korea
[3] Sunchon Natl Univ, Res Inst Life Pharmaceut Sci, Sunchon 57922, South Korea
[4] Ist Ric Farmacol Mario Negri IRCCS, Via Masa 19, I-20156 Milan, Italy
[5] Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, Via E Orabona 4, I-70125 Bari, Italy
[6] Ahalia Sch Pharm, Dept Pharmaceut Chem, Div Drug Design, Palakkad 678557, Kerala, India
[7] Ahalia Sch Pharm, Dept Pharmaceut Chem, Med Chem Res Lab, Palakkad 678557, Kerala, India
基金
新加坡国家研究基金会;
关键词
Chalcone; MAO inhibition; Kinetics; Reversibility; Molecular docking; MONOAMINE-OXIDASE-B; 2H-CHROMEN-2-ONE DERIVATIVES; THIENYL CHALCONES; BIOCHEMISTRY; IDENTIFICATION; MECHANISM; DISCOVERY; INSIGHTS;
D O I
10.1016/j.bioorg.2019.103335
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The present study documents the synthesis of oxygenated chalcone (O1-O26) derivatives and their abilities to inhibit monoamine oxidases. All 26 derivatives examined showed potent inhibitory activity against MAO-B. Compound O23 showed the greatest inhibitory activity against MAO-B with an IC50 value of 0.0021 mu M, followed by compounds O10 and O17 (IC50 = 0.0030 and 0.0034 mu M, respectively). In addition, most of the derivatives potently inhibited MAO-A and O6 was the most potent inhibitor with an IC50 value of 0.029 mu M, followed by O3, O4, O9, and O2 (IC50 = 0.035, 0.053, 0.072, and 0.082 mu M, respectively). O23 had a high selectivity index (SI) value for MAO-B of 138.1, and O20 (IC50 value for MAO-B= 0.010 mu M) had an extremely high SI of >4000. In dialysis experiments, inhibitions of MAO-A and MAO-B by O6 and O23, respectively, were recovered to their respective reversible reference levels, demonstrating both are reversible inhibitors. Kinetic studies revealed that O6 and O23 competitively inhibited MAO-A and MAO-B, respectively, with respective Ki values of 0.016 +/- 0.0007 and 0.00050 +/- 0.00003 mu M. Lead compound are also non-toxic at 200 mu g/mL in normal rat spleen cells. Molecular docking simulations and subsequent Molecular Mechanics/Generalized Born Surface Area calculations provided a rationale that explained experimental data.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Synthesis, Biological Evaluation, and Molecular Simulation of Chalcones and Aurones as Selective MAO-B Inhibitors
    Morales-Camilo, Nicole
    Salas, Cristian O.
    Sanhueza, Claudia
    Espinosa-Bustos, Christian
    Sepulveda-Boza, Silvia
    Reyes-Parada, Miguel
    Gonzalez-Nilo, Fernando
    Caroli-Rezende, Marcos
    Fierro, Angelica
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (06) : 685 - 695
  • [2] Design, synthesis and biological evaluation of novel benzocoumarin derivatives as potent inhibitors of MAO-B activity
    Meletli, Furkan
    Gunduz, Cihan
    Alparslan, Mustafa Muhlis
    Attar, Azade
    Demir, Serap
    Iskit, Ece
    Danis, Ozkan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 113
  • [3] Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors
    Matos, Maria Joao
    Vina, Dolores
    Picciau, Carmen
    Orallo, Francisco
    Santana, Lourdes
    Uriarte, Eugenio
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (17) : 5053 - 5055
  • [4] Identification of Indole-Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO-B Inhibitors
    Sasidharan, Rani
    Manju, Sreedharannair Leelabaiamma
    Ucar, Gulberk
    Baysal, Ipek
    Mathew, Bijo
    ARCHIV DER PHARMAZIE, 2016, 349 (08) : 627 - 637
  • [5] Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors
    Cecen, Muhammed
    Oh, Jong Min
    Ozdemir, Zeynep
    Buyuktuncel, Saliha Ebru
    Uysal, Mehtap
    Abdelgawad, Mohamed A.
    Musa, Arafa
    Gambacorta, Nicola
    Nicolotti, Orazio
    Mathew, Bijo
    Kim, Hoon
    MOLECULES, 2020, 25 (22):
  • [6] Development of selective and reversible pyrazoline based MAO-B inhibitors: Virtual screening, synthesis and biological evaluation
    Mishra, Nibha
    Sasmal, D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (07) : 1969 - 1973
  • [7] Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors
    Gaspar, Alexandra
    Reis, Joana
    Fonseca, Andre
    Milhazes, Nuno
    Vina, Dolores
    Uriarte, Eugenio
    Borges, Fernanda
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (02) : 707 - 709
  • [8] Hydroxycoumarins as selective MAO-B inhibitors
    Serra, Silvia
    Ferino, Giulio
    Joao Matos, Maria
    Vazquez-Rodriguez, Saleta
    Delogu, Giovanna
    Vina, Dolores
    Cadoni, Enzo
    Santana, Lourdes
    Uriarte, Eugenio
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 258 - 261
  • [9] REVERSIBLE, SELECTIVE INHIBITORS OF MAO-A AND MAO-B
    KINEMUCHI, H
    TOYOSHIMA, Y
    ARAI, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 1987, 43 : P62 - P62
  • [10] A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors
    Matos, Maria Joao
    Vina, Dolores
    Quezada, Elias
    Picciau, Carmen
    Delogu, Giovanna
    Orallo, Francisco
    Santana, Lourdes
    Uriarte, Eugenio
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (12) : 3268 - 3270